SLCO4A1 and invasive breast carcinoma: Additionally, the expression of SLCO4A1-AS1 was consistently downregulated in both breast invasive carcinoma (BRCA) and liver hepatocellular carcinoma (LIHC) tissues (Fig. 1C).